Research output per year
Research output per year
Fingerprint
Dive into the research topics where Teresa Calimeri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients
Wilson, M. R., Eyre, T. A., Kirkwood, A. A., Wong Doo, N., Soussain, C., Choquet, S., Martinez-Calle, N., Preston, G., Ahearne, M., Schorb, E., Moles-Moreau, M. P., Ku, M., Rusconi, C., Khwaja, J., Narkhede, M., Lewis, K. L., Calimeri, T., Durot, E., Renaud, L., Øvlisen, A. K. & 30 others, , Apr 21 2022, In: Blood. 139, 16, p. 2499-2511 13 p.Research output: Contribution to journal › Article › peer-review
-
A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the “CARMEN” phase II trial
Ferreri, A. J. M., Cattaneo, C., Lleshi, A., Verga, L., Allione, B., Facchetti, F., Ponzoni, M., Foppoli, M., Ferrari, D., Rigacci, L., Pecciarini, L., Donadoni, G., Fumagalli, L., Sassone, M., Calimeri, T., Rossi, G., Spina, M. & Re, A., Jan 2021, In: British Journal of Haematology. 192, 1, p. 119-128 10 p.Research output: Contribution to journal › Article › peer-review
-
A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the “CARMEN” phase II trial
Ferreri, A. J. M., Cattaneo, C., Lleshi, A., Verga, L., Allione, B., Facchetti, F., Ponzoni, M., Foppoli, M., Ferrari, D., Rigacci, L., Pecciarini, L., Donadoni, G., Fumagalli, L., Sassone, M., Calimeri, T., Rossi, G., Spina, M. & Re, A., Jan 2021, In: British Journal of Haematology. 192, 1, p. 119-128 10 p.Research output: Contribution to journal › Article › peer-review
-
A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the “CARMEN” phase II trial: British Journal of Haematology
Ferreri, AJM., Cattaneo, C., Lleshi, A., Verga, L., Allione, B., Facchetti, F., Ponzoni, M., Foppoli, M., Ferrari, D., Rigacci, L., Pecciarini, L., Donadoni, G., Fumagalli, L., Sassone, M., Calimeri, T., Rossi, G., Spina, M. & Re, A., 2021, In: Br. J. Haematol.. 192, 1, p. 119-128 10 p.Research output: Contribution to journal › Article › peer-review
-
Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center
Giuffrè, C., Cicinelli, M. V., Marchese, A., Modorati, G. M., Brambati, M., Ferreri, A. J. M., Calimeri, T., Ponzoni, M., Bandello, F. & Miserocchi, E., 2021, In: Ocular Immunology and Inflammation. 29, 3, p. 472-478 7 p.Research output: Contribution to journal › Article › peer-review